Aprea Therapeutics, Inc. (APRE)
0.538
+0.02
(+4.87%)
USD |
NASDAQ |
Oct 28, 16:00
0.538
0.00 (0.00%)
After-Hours: 20:00
Aprea Therapeutics Price to Book Value : 0.1733 for Oct. 28, 2026
Price to Book Value Chart
Historical Price to Book Value Data
| Date | Value |
|---|---|
| October 27, 2026 | 0.1652 |
| October 26, 2026 | 0.1446 |
| October 23, 2026 | 0.1667 |
| October 22, 2026 | 0.1744 |
| October 21, 2026 | 0.1805 |
| October 20, 2026 | 0.1808 |
| October 19, 2026 | 0.1715 |
| October 16, 2026 | 0.1882 |
| October 15, 2026 | 0.1989 |
| October 14, 2026 | 0.1878 |
| October 13, 2026 | 0.1933 |
| October 12, 2026 | 0.191 |
| October 09, 2026 | 0.1947 |
| October 08, 2026 | 0.1798 |
| October 07, 2026 | 0.1949 |
| October 06, 2026 | 0.2047 |
| October 05, 2026 | 0.2176 |
| October 02, 2026 | 0.2239 |
| October 01, 2026 | 0.233 |
| September 30, 2026 | 0.2416 |
| September 29, 2026 | 0.2479 |
| September 28, 2026 | 0.2422 |
| September 25, 2026 | 0.2451 |
| September 24, 2026 | 0.2511 |
| September 23, 2026 | 0.2512 |
| Date | Value |
|---|---|
| September 22, 2026 | 0.2359 |
| September 21, 2026 | 0.2374 |
| September 18, 2026 | 0.2448 |
| September 17, 2026 | 0.2416 |
| September 16, 2026 | 0.2353 |
| September 15, 2026 | 0.2412 |
| September 14, 2026 | 0.2517 |
| September 11, 2026 | 0.2493 |
| September 10, 2026 | 0.2542 |
| September 09, 2026 | 0.2549 |
| September 08, 2026 | 0.2689 |
| September 04, 2026 | 0.2558 |
| September 03, 2026 | 0.2597 |
| September 02, 2026 | 0.2641 |
| September 01, 2026 | 0.2692 |
| August 31, 2026 | 0.2577 |
| August 28, 2026 | 0.2701 |
| August 27, 2026 | 0.277 |
| August 26, 2026 | 0.3157 |
| August 25, 2026 | 0.306 |
| August 24, 2026 | 0.2594 |
| August 21, 2026 | 0.2062 |
| August 20, 2026 | 0.2062 |
| August 19, 2026 | 0.2161 |
| August 18, 2026 | 0.2164 |
Price to Book Ratio Definition
Price to book value is a valuation ratio that is measured by stock price / book value per share. The book value is essentially the tangible accounting value of a firm compared to the market value that is shown.
Price to Book Value Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Price to Book Value Benchmarks
| Zymeworks, Inc. | 25.85 |
| Rhythm Pharmaceuticals, Inc. | 63.34 |
| ACADIA Pharmaceuticals, Inc. | 2.675 |
| Alnylam Pharmaceuticals, Inc. | 22.96 |
| Anika Therapeutics, Inc. | 2.097 |
Price to Book Value Related Metrics
| PS Ratio | 2126.91 |
| Price | 0.538 |
| Earnings Yield | -200.1% |
| Market Cap | 6.666M |